Related Experiment Video
Updated: Jun 25, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
Published on: December 18, 2012
Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model
Shiro Higaki1, Keizo Watanabe, Motoki Itahashi
1Department of Ophthalmology, Kinki University School of Medicine, Osaka-Sayama, Japan. higaki@ganka.med.kindai.ac.jp
Purpose:
To examine the effects of COX inhibitors on suppressing HSV-1 reactivation in a mouse model.
Methods:
BALB/c mice were latently infected with HSV-1 and treated by 0.1% bromfenac Na eye drops, 0.1% pranoprofen eye drops, 0.1 mg oral etodolac 4 times/day, and saline for 4 days. After reactivating the latent HSV-1, we swabbed the mouse ocular surface for the culture of the infectious virus and assessed the viral loads in the eyes and trigeminal ganglia (TGs) using real-time PCR to determine the treatment efficacies.
Results:
With stimulated reactivation, 10 of 24 (41.7%), 5 of 10 (50.0%), 17 of 25 (68%), and 16 of 22 eyes (72.7%) showed positive swab results in the bromfenac Na, etodolac, pranoprofen, and saline groups, respectively; and a significant difference was seen only between the bromfenac Na and saline groups (p = 0.033). None of the three drug-treated groups showed any significant difference from the saline group in the viral DNA in the eyes and TGs (p > 0.05).
Conclusions:
Bromfenac Na eye drops can suppress HSV-1 reactivation.
Insights
Bromfenac sodium eye drops showed potential in suppressing herpes simplex virus type 1 (HSV-1) reactivation in a mouse model. Further research is needed to confirm its efficacy in clinical settings.
Area of Science:
- Ophthalmology
- Virology
- Pharmacology
Background:
- Herpes simplex virus type 1 (HSV-1) establishes lifelong latency in sensory neurons.
- Reactivation of HSV-1 can lead to ocular disease, including herpetic keratitis.
- Cyclooxygenase (COX) inhibitors are explored for their potential antiviral properties.
Purpose of the Study:
- To investigate the efficacy of COX inhibitors in suppressing HSV-1 reactivation.
- To evaluate bromfenac sodium, pranoprofen, and etodolac for their ability to prevent HSV-1 recurrence in a mouse model.
Main Methods:
- BALB/c mice with latent HSV-1 infection were treated with bromfenac sodium, pranoprofen, etodolac, or saline eye drops.
- Latent HSV-1 was reactivated, and ocular surface swabs were cultured for infectious virus.
- Viral loads in eyes and trigeminal ganglia (TGs) were quantified using real-time PCR.
Main Results:
- Bromfenac sodium eye drops demonstrated a statistically significant reduction in positive HSV-1 swab results compared to saline (p = 0.033).
- No significant differences in viral DNA levels were observed in the eyes or TGs among the drug-treated groups and the saline control group.
- Pranoprofen and etodolac did not show significant suppression of HSV-1 reactivation compared to the saline group.
Conclusions:
- Bromfenac sodium eye drops exhibit potential in suppressing HSV-1 reactivation.
- Current COX inhibitors tested did not significantly reduce viral loads in ocular tissues or TGs during reactivation.
- Further studies are warranted to elucidate the precise mechanisms and clinical applicability of bromfenac sodium for HSV-1 suppression.
Related Concept Videos
Herpes
Genital Herpes
Hypersensitivity Reactions: Cytolytic Reactions
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors
Cytomegalovirus Disease

